The Open Loop with Chay Carter

In this episode of The Open Loop, Chay Carter is joined by Ryan Glatt and Lauren Sergio of NERON. Ryan is a Brain Health Coach and Director of the FitBrain℠ Program at Pacific Neuroscience Institute, where his work focuses on brain health, exercise science, clinical exergaming, dual-task training, and cognitive wellness. Lauren is a Professor and neuroscientist at York University whose work focuses on movement control, cognitive-motor integration, and how the brain coordinates thinking and movement. We explore how NERON is using simple movement-based tasks to assess more complex brain communication, and why thinking while moving could become a valuable part of brain health measurement. Ryan and Lauren also discuss ageing, concussion, fall risk, sport, military applications, and the challenge of making brain health assessment more accessible outside traditional clinical settings. Key takeaways: 🔹 Why thinking and moving together can reveal more than cognition or movement alone 🔹 How neuromotor and visuomotor control relate to everyday brain health 🔹 Why dual-task assessment may help identify risk earlier than traditional screening tools 🔹 How NERON uses simple movement tasks to assess complex brain communication 🔹 Where this technology could be used across ageing, concussion, sport, military and community health settings Host: Chay Carter Founder, Carter Sciences | Co-Founder, Reccy Neuro LinkedIn: https://www.linkedin.com/in/chay-carter/ Guests: Ryan Glatt Brain Health Coach | Director, FitBrain℠ Program at Pacific Neuroscience Institute LinkedIn: https://www.linkedin.com/in/ryan-glatt-ms-cpt-nbc-hwc-50ba3664/ Lauren Sergio Professor and Neuroscientist, York University LinkedIn: https://ca.linkedin.com/in/lauren-sergio-2793351a The Open Loop is a podcast exploring the people, companies, and ideas shaping the future of neurotechnology. 🔔 Subscribe for weekly conversations with the founders, researchers, operators, and industry leaders building what comes next in brain health, medicine, and technology. If you enjoyed this episode, please subscribe, leave a review, and share it with someone interested in neurotechnology. New episodes of The Open Loop drop weekly. Sponsor: This episode is sponsored by Reccy Neuro — the home of neurotech. Jobs, companies, investors, events, Cortex industry intelligence, and specialist resources for the neurotech market. Learn more about Reccy Neuro here: https://neuro.reccy.dev/

In this episode of The Open Loop, Chay Carter is joined by Adam Fraser, Chief Operating Officer at Omniscient Neurotechnology. Adam shares how Omniscient is taking connectomics out of the lab and into clinical practice, using AI and MRI data to help decode the brain’s structural and functional networks. We explore how connectomics can support neurosurgical planning today, why brain network mapping could become important across DBS, stroke, coma, epilepsy and psychiatry, and what it takes to build a scalable neurotechnology platform inside the US healthcare system. Adam also discusses Omniscient’s go-to-market journey, reimbursement, medical education, the company’s US focus, the role of AI in brain mapping, and why mental health remains a long-term North Star for the business. Key takeaways: 🔹 What connectomics means and why it matters for brain health 🔹 How structural and functional connectomes act like “roads and traffic” for the brain 🔹 Why neurosurgical planning was Omniscient’s first major clinical focus 🔹 How connectomics could support future work in DBS, stroke, coma, epilepsy and psychiatry 🔹 Why bringing new neurotechnology into the US healthcare system requires evidence, reimbursement and medical education Host: Chay Carter Founder, Carter Sciences | Co-Founder, Reccy Neuro LinkedIn: https://www.linkedin.com/in/chay-carter/ Guest: Adam Fraser Chief Operating Officer, Omniscient Neurotechnology LinkedIn: https://www.linkedin.com/in/adam-fraser-23202133/ The Open Loop is a podcast exploring the people, companies, and ideas shaping the future of neurotechnology. 🔔 Subscribe for weekly conversations with the founders, researchers, operators, and industry leaders building what comes next in brain health, medicine, and technology. If you enjoyed this episode, please subscribe, leave a review, and share it with someone interested in neurotechnology. New episodes of The Open Loop drop weekly. Sponsor: This episode is sponsored by Reccy Neuro — the home of neurotech. Jobs, companies, investors, events, Cortex industry intelligence, and specialist resources for the neurotech market. Learn more about Reccy Neuro here: https://neuro.reccy.dev/

In this episode of The Open Loop, Chay Carter is joined by Jonathan “JB” Berent, Founder and CEO of NextSense. JB shares the story behind NextSense, from his early fascination with sleep and lucid dreaming to a Google X project exploring deep sleep enhancement, in-ear EEG, and brain-sensing wearables. We explore why the ear is such a compelling form factor for brain data, how NextSense is building smartbuds for sleep, focus and calm, and what it takes to turn advanced neurotechnology into a consumer product people actually use. We also discuss lucid dreaming research, acoustic stimulation, fundraising, product-market fit, manufacturing, ARPA-H’s REST programme, and future directions including more sensors, tVNS, and closed-loop sleep modulation. Key takeaways: 🔹 Why NextSense built around in-ear EEG and smartbud form factor 🔹 How a Google X sleep project evolved into a consumer neurotech company 🔹 Why longitudinal brain data could shape the next generation of wearables 🔹 What founders need to understand about product-market fit in consumer neurotech 🔹 How closed-loop sleep modulation, audio and future sensors could expand the platform Guest: Jonathan “JB” Berent Founder and CEO, NextSense LinkedIn: https://www.linkedin.com/in/jonathan-berent/ Host: Chay Carter Founder, Carter Sciences | Co-Founder, Reccy Neuro LinkedIn: https://www.linkedin.com/in/chay-carter/ Key Chapters: 00:39 Introduction to NextSense and Brain-Sensing Smartbuds 01:40 From Stanford, Lucid Dreaming and Google to NextSense 04:56 Lucid Dreaming, EEG and Dream Communication 07:46 Learning Neuroscience and Building at Google X 11:56 Spinning NextSense Out of Google 14:54 Fundraising, Consumer Neurotech and Investor Challenges 21:53 Product-Market Fit and the Toothbrush Test 27:28 Why NextSense Chose Earbuds for Brain Data The Open Loop is a podcast exploring the people, companies, and ideas shaping the future of neurotechnology. 🔔 Subscribe for weekly conversations with the founders, researchers, operators, and industry leaders building what comes next in brain health, medicine, and technology. If you enjoyed this episode, please subscribe, leave a review, and share it with someone interested in neurotechnology. New episodes of The Open Loop drop weekly. Sponsor: This episode is sponsored by Reccy Neuro — the home of neurotech. Jobs, companies, investors, events, Cortex industry intelligence, and specialist resources for the neurotech market. Learn more about Reccy Neuro here: https://neuro.reccy.dev/

In this episode of The Open Loop, Chay Carter is joined by William Sauvé, MD, Chief Medical Officer at Osmind. William shares his journey from Navy psychiatry and combat mental health care to TMS, interventional psychiatry, Greenbrook, and his current work helping scale mental health infrastructure at Osmind. We explore how psychiatry can move beyond traditional medication management, the access challenge facing mental health care, and the role of treatments like TMS, ketamine, esketamine, and emerging psychedelic therapies. We also discuss real-world evidence, fMRI-guided TMS, accelerated treatment protocols, REMS workflows, psychiatric EHRs, and why interventional psychiatry could become a force multiplier for mental health care. Key takeaways: 🔹 Why mental health care needs a “force multiplier” to meet patient demand 🔹 How TMS has evolved from early adoption challenges to broader clinical use 🔹 Why targeting, precision and real-world evidence matter in brain stimulation 🔹 How Osmind supports workflows for TMS, ketamine and esketamine clinics 🔹 Why emerging psychedelic therapies could change the logistics of psychiatric care Host: Chay Carter Founder, Carter Sciences | Co-Founder, Reccy Neuro LinkedIn: https://www.linkedin.com/in/chay-carter/ Guest: William Sauvé, MD Chief Medical Officer, Osmind LinkedIn: https://www.linkedin.com/in/william-sauv%C3%A9-md-45009813/ The Open Loop is a podcast exploring the people, companies, and ideas shaping the future of neurotechnology. 🔔 Subscribe for weekly conversations with the founders, researchers, operators, and industry leaders building what comes next in brain health, medicine, and technology. If you enjoyed this episode, please subscribe, leave a review, and share it with someone interested in neurotechnology. New episodes of The Open Loop drop weekly. Sponsor: This episode is sponsored by Reccy Neuro — the home of neurotech. Jobs, companies, investors, events, Cortex industry intelligence, and specialist resources for the neurotech market. Learn more about Reccy Neuro here: https://neuro.reccy.dev/

In this episode of The Open Loop, Chay Carter is joined by Balder Onarheim, Founder and CEO of PlatoScience. Balder shares his journey from the Norwegian army and engineering design into creativity research, brain stimulation, and building at-home tDCS devices for mental health care. This is a practical conversation about transcranial direct-current stimulation, depression, neuroplasticity, usability, regulation, and what it takes to make brain stimulation safe and accessible outside the clinic. We explore how PlatoScience approaches medical-grade at-home tDCS, why the company works through clinicians, and how design, aesthetics, treatment adherence, and patient experience all shape the future of neuromodulation. Key takeaways: 🔹 Why PlatoScience is focused on at-home tDCS for depression 🔹 How tDCS changes neuronal thresholds without forcing brain activity 🔹 Why medical-grade usability matters for patient adherence 🔹 Why Balder believes mental health care should keep a human in the loop 🔹 How regulation could shape the future of non-invasive brain stimulation Host: Chay Carter Founder, Carter Sciences | Co-Founder, Reccy Neuro LinkedIn: https://www.linkedin.com/in/chay-carter/ Guest: Balder Onarheim Founder and CEO, PlatoScience LinkedIn: https://www.linkedin.com/in/baldero/ Learn more about PlatoScience: https://www.platoscience.com/ Key Chapters: 00:39 Introduction to PlatoScience and At-Home tDCS 01:55 From the Norwegian Army to Brain Stimulation 05:51 From Biohacking to Medical-Grade tDCS 07:39 Depression, Ageing and Neurodivergence 09:50 How tDCS and TES Work 16:32 PlatoScience’s Device and Clinician-Led Model 29:25 Design, Treatment Sessions and Patient Usability 38:54 EU Regulation and the Future of Brain Stimulation The Open Loop is a podcast exploring the people, companies, and ideas shaping the future of neurotechnology. 🔔 Subscribe for weekly conversations with the founders, researchers, operators, and industry leaders building what comes next in brain health, medicine, and technology. If you enjoyed this episode, please subscribe, leave a review, and share it with someone interested in neurotechnology. New episodes of The Open Loop drop weekly. Sponsor: This episode is sponsored by Reccy Neuro — the home of neurotech. Jobs, companies, investors, events, Cortex industry intelligence, and specialist resources for the neurotech market. Learn more about Reccy Neuro here: https://neuro.reccy.dev/